“…The receptor binding affinities of synthesized compounds toward the DOR, KOR, and MOR subtypes were studied using transiently transfected human embryonic kidney (HEK) 293T cells using [ 3 H]diprenorphine as the radioligand ( Table 1 ), following the procedure as described previously. 18 , 20 DAMGO [MOR, K i = 25 ± 4.4 nM ( n = 9); DOR, K i = 1000 ± 150 nM ( n = 6); KOR, K i = 4200 ± 1200 nM ( n = 6)), Leu-Enk (MOR, K i = 160 ± 30 nM ( n = 9); DOR, K i = 6.8 ± 0.58 nM ( n = 6); KOR, K i = 15,000 ± 1200 nM ( n = 6)] and naloxone [MOR, K i = 3.3 ± 0.33 nM ( n = 18); DOR, K i = 56 ± 4.6 nM ( n = 18); KOR, K i = 16 ± 3.9 nM ( n = 10)] were included as references. The potency of the compounds was determined in Chinese hamster ovary (CHO) cells stably transfected with the DOR, KOR, and MOR by measuring the agonist-mediated inhibition of intracellular cAMP response ( Figure 2 ), using references deltorphin (DOR), U50488 (KOR), and DAMGO (MOR).…”